Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    The AstraZeneca share price has smashed the FTSE 100 in 2018. I say it could do so again in 2019

    | Rupert Hargreaves

    Rupert Hargreaves explains why he thinks AstraZeneca plc (LON:AZN) will continue to outperform the FTSE 100 (INDEXFTSE: UKX).

    Read more »

    Investing Articles

    Why I think AstraZeneca should be in your 2019 share portfolio

    | Tezcan Gecgil, PhD

    AstraZeneca plc (LON: AZN) has multiple positive catalysts and I see a buying opportunity right now.

    Read more »

    Investing Articles

    3 FTSE 100 shares I think are better than a buy-to-let property

    | Andy Ross

    If you're thinking of investing in buy-to-let, these three stocks could be a better buy, says Andy Ross.

    Read more »

    Investing Articles

    Could AstraZeneca boost your retirement income as the State Pension age rises?

    | Peter Stephens

    Could AstraZeneca plc’s (LON: AZN) dividend prospects help to offset the challenges posed by the State Pension?

    Read more »

    Investing Articles

    Forget 1.5% from a cash ISA. FTSE 100 member AstraZeneca is up by 20% in 2018

    | Roland Head

    Roland Head asks whether FTSE 100 (INDEXFTSE:UKX) dividend stock AstraZeneca plc (LON:AZN) deserves a buy rating.

    Read more »

    Investing Articles

    Don’t panic! How I think you can Brexit-proof your shares portfolio with these FTSE 100 dividend stocks

    | Royston Wild

    If you're worried about Brexit, then I think shopping for these FTSE 100 (INDEXFTSE: UKX) dividend stocks should be at…

    Read more »

    Investing Articles

    Can the AstraZeneca share price continue to smash the FTSE 100?

    | G A Chester

    G A Chester discusses the valuation and prospects of FTSE 100 (INDEXFTSE:UKX) pharma stock AstraZeneca plc (LON:AZN).

    Read more »

    Investing Articles

    Is the wait finally over for the AstraZeneca share price?

    | Alan Oscroft

    Investors have waited patiently for AstraZeneca plc (LON: AZN) to get back to earnings growth. I don't think there's much…

    Read more »

    Investing Articles

    Have £1,000 to invest? Why I’d buy FTSE 100-member AstraZeneca over a cash ISA

    | Peter Stephens

    AstraZeneca plc (LON:AZN) could offer stronger growth potential than the FTSE 100 (INDEXFTSE:UKX) or a cash ISA.

    Read more »

    Investing Articles

    Should I pile into Lloyds or AstraZeneca in this volatile market?

    | Kevin Godbold

    Lloyds Banking Group plc (LON: LLOY) and AstraZeneca plc (LON: AZN) are very different beasts. Here’s which one I’d choose.

    Read more »

    Investing Articles

    Why I believe investing in these FTSE 100 dividend stocks could make you a millionaire retiree

    | Royston Wild

    Royston Wild discusses two dynamic dividend stocks from the FTSE 100 (INDEXFTSE: UKX) that could make you richer.

    Read more »

    Investing Articles

    Why I’d buy and hold the AstraZeneca share price for the next 20 years

    | Rupert Hargreaves

    Rupert Hargreaves outlines why he believes AstraZeneca plc (LON: AZN) could help you retire early.

    Read more »